FDA NDC Directory · JSON-LD · Markdown

Giapreza

NDC 68547-005 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameangiotensin II
Labeler / ManufacturerLa Jolla Pharmaceutical Company
Marketing categoryNew Drug Application (innovator) · App NDA209360
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsANGIOTENSIN II (.5 mg/mL)
Marketing started20220915
Package count1

External sources

Source: openFDA. Public-domain (CC0).